Reevaluating the Health-Related Quality of Life Impact and the Economic Burden of Urgency Urinary Incontinence  Anastasios Athanasopoulos, Salvador Arlandis.

Slides:



Advertisements
Similar presentations
Volume 50, Issue 3, Pages (September 2006)
Advertisements

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Volume 41, Issue 3, Pages (March 2002)
Pascal Rischmann  European Urology Supplements 
Female Urinary Incontinence in the West of Turkey: Prevalence, Risk Factors and Impact on Quality of Life  Izzet Kocak, Pinar Okyay, Mehmet Dundar, Haluk.
Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management  Michael O’Leary  European Urology Supplements 
Management of Acute and Chronic Retention in Men
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Debra E. Irwin, Ian Milsom, Zoe Kopp, Paul Abrams  European Urology 
Volume 64, Issue 4, Pages (October 2013)
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 6, Pages (December 2006)
Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer  Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.
Volume 65, Issue 1, Pages (January 2014)
Bladder Cancer: Management and Future Directions
Volume 45, Issue 4, Pages (April 2004)
Volume 61, Issue 1, Pages (January 2012)
Martin C. Michel  European Urology Supplements 
Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer  Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Bladder Cancer: A Major Public Health Issue
Back to the Future: Introduction and Conclusions
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 52, Issue 3, Pages (September 2007)
Obstetrics and Gynecology Clinics
Volume 59, Issue 4, Pages (April 2011)
Long-Term Management of Overactive Bladder with Antimuscarinic Agents
Volume 48, Issue 4, Pages (October 2005)
Volume 60, Issue 1, Pages (July 2011)
Volume 56, Issue 1, Pages (July 2009)
Counselling the Prostate Cancer Patient
Volume 44, Issue 5, Pages (November 2003)
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Volume 51, Issue 4, Pages (April 2007)
An Update of Current Practice in Hypospadias Surgery
Richard C. Harkaway  European Urology Supplements 
Tim Schneider  European Urology Supplements 
Genitourinary symptoms in the menopausal transition
Philip Toozs-Hobson, Pallavi Latthe  European Urology Supplements 
Ian Milsom  European Urology Supplements 
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Optimal Testosterone Control and Eligard®
Impact of Tamsulosin OCAS on Energy of Patients with LUTS/BPH
When to Treat the Prostate, the Bladder, or Both?
The Hallmarks of BPH Progression and Risk Factors
Sergio Bracarda  European Urology Supplements 
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Pharmacotherapy in Stress and Mixed Incontinence
New Trends in Managing the Prostate Cancer Patient
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
William D Steers  European Urology Supplements 
A Cross-Sectional, Population-Based, Multinational Study of the Prevalence of Overactive Bladder and Lower Urinary Tract Symptoms: Results from the EPIC.
Martin Michel, Jean de la Rosette  European Urology Supplements 
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer  P. Mongiat-Artus, P. Teillac 
The Burden of Stress Urinary Incontinence
Profile of Silodosin European Urology Supplements
Economic Burden of Bladder Cancer Across the European Union
New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Treatment Options in Prostate Cancer Once Primary Therapy Fails
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Classification of Mixed Incontinence
Economic and Social Impact of OAB
The Impact of Premature Ejaculation on Partners and Relationships
Volume 52, Issue 6, Pages (December 2007)
Emmanuel Chartier-Kastler, Andrea Tubaro  European Urology Supplements 
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Jan Roigas  European Urology Supplements 
Michael Marberger  European Urology Supplements 
Presentation transcript:

Reevaluating the Health-Related Quality of Life Impact and the Economic Burden of Urgency Urinary Incontinence  Anastasios Athanasopoulos, Salvador Arlandis Guzmán  European Urology Supplements  Volume 10, Issue 1, Pages 3-7 (March 2011) DOI: 10.1016/j.eursup.2011.01.001 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Prevalence (percentage) of urinary incontinence subtypes among participants with overactive bladder. Reprinted from Eur Urol 2006;50, Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study, p. 1306–15. Copyright 2010, with permission from Elsevier [4]. OAB=overactive bladder; MUI=mixed urinary incontinence; SUI=stress urinary incontinence; UI=urinary incontinence; UUI=urgency urinary incontinence. European Urology Supplements 2011 10, 3-7DOI: (10.1016/j.eursup.2011.01.001) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 Mean Short Form-36 scores for individuals with overactive bladder with or without urgency incontinence, and age- and sex-matched controls. With kind permission from Springer Science+Business Media: World J Urol, Prevalence and burden of overactive bladder in the United States, 20:2003, 327–36, Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ, Fig. 3 [13]. European Urology Supplements 2011 10, 3-7DOI: (10.1016/j.eursup.2011.01.001) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 3 Total estimated costs of overactive bladder in five European countries in 2000 (euros, billions). Reprinted from Eur Urol 2006;50, Reeves P, Irwin D, Kelleher C, Milsom I, Kopp Z, Calvert N, Lloyd A. The current and future burden and cost of overactive bladder in five European countries, p. 1050–57. Copyright 2010, with permission from Elsevier [21]. European Urology Supplements 2011 10, 3-7DOI: (10.1016/j.eursup.2011.01.001) Copyright © 2011 European Association of Urology Terms and Conditions